The Role of Botulinum Toxin Type A in the Radiation Fibrosis Syndrome: A Preliminary Report

Archives of Physical Medicine and Rehabilitation

Volumn 89, Issue 3, 2008, Pages 417-421

  Stubblefield, Michael D ^a   Levine, Aaron ^b   Custodio, Christian M ^a   Fitzpatrick, Theresa ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Cancer; Dystonia; Fibrosis, radiation; Pain; Rehabilitation; Trigeminal neuralgia; Trismus

Indexed keywords

ANTIINFLAMMATORY AGENT; BOTULINUM TOXIN A; GABAPENTIN; MUSCLE RELAXANT AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DYSARTHRIA; DYSPHAGIA; FEMALE; FOREHEAD; HUMAN; INFECTION; INJECTION SITE; MALE; MASSETER MUSCLE; MUSCLE TIGHTNESS; MUSCLE WEAKNESS; MYOFIBROSIS; NEUROMUSCULAR BLOCKING; OCCUPATIONAL THERAPIST; PAIN; RADIATION INJURY; STERNOCLEIDOMASTOID MUSCLE; TRAPEZIUS MUSCLE; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA; TRISMUS;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; COHORT STUDIES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEOPLASMS; PAIN MEASUREMENT; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TORTICOLLIS; TREATMENT OUTCOME;

EID: 39449125007     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2007.11.022     Document Type: Article

References (26)

1. Royal M.A. The use of botulinum toxins in the management of pain and headache. Phys Med Rehabil Clin N Am 14 (2003) 805-820
2. Stubblefield M.D. Radiation fibrosis syndrome. In: Cooper G. (Ed). Therapeutic uses of Botox (2007), Humana Pr, Totowa 19-38
3. Lou J.S., Pleninger P., and Kurlan R. Botulinum toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasms. Mov Disord 10 (1995) 680-681
4. Van Daele D.J., Finnegan E.M., Rodnitzky R.L., Zhen W., McCullock T.M., and Hoffman H.T. Head and neck muscle spasms after radiotherapy. Management with botulinum toxin A injection. Arch Otolaryngol Head Neck Surg 128 (2002) 956-959
5. Wittekindt C., Liu W.C., Klaussmann J.P., and Guntinas-Lichius O. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection. Head Neck 26 (2004) 39-45
6. Okereke L.I., Stubblefield M.D., and Custodio C.M. Botulinum toxin type A for radiation-induced trismus and facial pain: a case report [abstract]. Arch Phys Med Rehabil 85 (2004) E37
7. Wittekindt C., Liu W.C., Preuss S.F., and Guntinas-Lichius O. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study. Laryngoscope 116 (2006) 1168-1171
8. Hauer-Jensen M., Fink L.M., and Wang J. Radiation injury and the protein C pathway. Crit Care Med 32 Suppl (2004) S325-S330
9. Saarto T., Janes R., Tenhunen M., and Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 6 (2002) 323-330
10. Libshitz H.I., DuBrow R.A., Loyer E.M., and Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur Radiol 6 (1996) 786-795
11. Portlock C.S., Boland P., Hays A.P., Antonescu C.R., and Rosenblum M.K. Nemaline myopathy: a possible late complication of Hodgkin's disease therapy. Hum Pathol 34 (2003) 816-818
12. Johansson S., Svensson H., Larsson L., and Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients: a long-term follow-up. Acta Oncol 39 (2000) 373-382
13. New P. Radiation injury to the nervous system. Curr Opin Neurol 14 (2001) 725-734
14. Delanian S., and Lefaix J.L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 17 (2007) 99-107
15. Johansson S., Svensson H., and Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiation Oncol Biol Phys 48 (2000) 745-750
16. Gillette E.L., Mahler P.A., Powers B.E., Gillette S.M., and Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 31 (1995) 1309-1318
17. Greenfield M.M., and Stark G.M. Post-irradiation neuropathy. AJR Am J Roentgenol 60 (1948) 617-622
18. Miller T.M., and Layzer R.B. Muscle cramps. Muscle Nerve 32 (2005) 431-442
19. Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol 251 Suppl 1 (2005) I1-I7
20. Karuman P.M., and Soo K.C. Motor innervation of the trapezius muscle: a histochemical study. Head Neck 18 (1996) 254-258
21. Tytherleigh-Strong G., Hirahara A., and Miniaci A. Rotator cuff disease. Curr Opin Rheumatol 13 (2001) 135-145
22. Welch M.J., Purkiss J.R., and Foster K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon 38 (2000) 245-258
23. Durham P.L., Cady R., and Cady R.K. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44 (2004) 35-42
24. Cui M., Li Z., You S., Khanijou S., and Aoki K.R. Mechanisms of the antinociceptive effect of subcutaneous BOTOX: inhibition of peripheral and central nociceptive processing [abstract]. Naunyn Schmiedebergs Arch Pharmacol 365 (2002) R17
25. Aoki K.R. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26 (2005) 785-793
26. Cui M., Khanijou S., Rubino J., and Aoki K.R. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107 (2004) 125-133